Clinical Trial Update: A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy, safety, and pharmacokinetics of oral rilzabrutinib versus placebo in adults with warm autoimmune hemolytic anemia; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• Rilzabrutinib (rilzabrutinib)

Snippet

Sponsor: Sanofi | Conditions: Autoimmune Haemolytic Anaemia | Phase 3 | Status: RECRUITING